Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-7450 in Acute Ischemic Stroke
NCT07233070Phase 2Completed
- Sponsor
- Fujian Shengdi Pharmaceuticals
- Start
- Oct 2025
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-7450 in ischemic stroke, sponsored by Fujian Shengdi Pharmaceuticals. Started Oct 2025; status: completed.
02
Drugs
HRS-7450
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07233070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07233070.